CLINICAL_TRIALS
trial_result
· 2018-11-05
Clinical Trial Update: Staccato Prochlorperazine Single Dose PK Study [Phase 1]
Summary
Phase 1 pharmacokinetic study of a single-dose Staccato formulation of prochlorperazine in migraine patients completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nova Pneuma Inc. | Conditions: Migraine | Phase 1 | Status: COMPLETED | Results posted: 2018-11-05